Dr. Greg Katz

Dr. Steve Nissen from Cleveland Clinic, a leading figure in lipoprotein(a) research, joins Dr. Greg Katz from NYU to delve into crucial insights about this underappreciated lipid layer. They discuss why Lp(a) is essential for evaluating cardiovascular risk and who should be tested. Listeners will learn about interpreting results, managing elevated levels, and the potential roles of aspirin and PCSK9 inhibitors. The episode highlights the evolving strategies in understanding and treating Lp(a), offering a fresh perspective on patient care.

Dr. Greg Katz, a cardiologist and assistant professor at NYU Langone Health, delves into strategies for preventing cardiovascular disease. He emphasizes a personalized approach using patient case studies to highlight the balance between lifestyle changes and medical treatments. Advanced lipid testing, including Apolipoprotein B and lipoprotein(a), is discussed alongside the evolving role of medications like statins and GLP-1 agonists. Katz also covers the intricate decision-making around aspirin use and the critical role of cardiac imaging in assessing risks.